Home » Areas of Work » Public Policy

Public Policy

2011 BIO International Convention Governors Highlight Reel
January 27, 2012

The 2011 BIO International Convention brought together over 15,000 leaders from industry,...

BIO Media Briefing Highlights 2012 Policy Priorities
January 25, 2012

BIO President & CEO Jim Greenwood and Tom Watkins, President & CEO of Human Genome...

Podcast: BIO Media Briefing Highlights 2012 Policy Priorities
January 25, 2012

BIO President & CEO Jim Greenwood and Tom Watkins, President & CEO of Human Genome...

BIO's 2012 Legislative Priorities - Part II
January 17, 2012

BIOtech-NOW's Tracy Cooley discusses the legislative year ahead with Brent Del Monte, BIO's Vice...

More Articles →

Key Documents

    

  
  
  
      

      

  
                

                  
              
  

                
  

  
  

                What Legal Issues are Presented by Biosimilars?
  

  
  

                

  

          		
                  
              
  

                U.S. Economic Impact of Advanced Biofuels Production
  

  
  

                

	Total job creation, accounting for economic multiplier effects, could reach 123,000 in 2012,...

  

          		
                  
                      
              

      


    

  
  
  
  
  
  

   




  


  
  

    

    
  
  
      

        
Letters, Testimony & Comments

  

      
  

                BIO Comments on CMS Proposed Methodology for 2013 Star Ratings for Medicare Advantage and Prescription Drug Plans
  

  
  

                January 20 2012
  

  
  

                
	Re: Request for Comments Regarding Enhancements to the Part C and Part D Plan Ratings

	The Biotechnology Industry Organization (BIO)...
  

  

  		
	  

      
  

                Orphan Drugs: BIO Submits Comments on Orphan Drug Regulations
  

  
  

                January 17 2012
  

  
  

                
	 

	Dear Sir/Madam:

	The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the...
  

  

  		
	  

      
  

                Bar Code Technologies: BIO Comments on FDA's Bar Code Technologies for Drugs and Biological Products; Retrospective Review under Executive Order 13563
  

  
  

                January 9 2012
  

  
  

                
	 

	 

	Dear Sir/Madam:

	 

	The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA...
  

  

  		
	  

      
  

                Drug Shortages: BIO Comments on Center for Drug Evaluation and Research (CDER), Approach to Addressing Drug Shortage; Public Workshop; Request for Comments
  

  
  

                December 23 2011
  

  
  

                
	 

	The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to submit...
  

  

  		
	  

      
  

                Biosimilar User Fees: BIO Testifies at Biosimilar User Fee Public Hearing
  

  
  

                December 16 2011
  

  
  

                
	Dear Sir/Madam:

	On behalf of the Biotechnology Industry Organization, thank you for the opportunity to comment on the proposed user fee...
  

  

      

  
  
  
      


  
    More Letters, Testimony & Comments →  


  
  
  

   




  


  
  

    

    
  
  
      

        
Press Releases

  

      
  

                Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO
  

  
  

                February 9 2012
  

  
  

                
	Patient Safety Must Remain Top Priority

	Washington, D.C. (February 9, 2012) — Biotechnology Industry...
  

  

  		
	  

      
  

                Biotechnology Can Provide Foundation for A U.S. Economy “Built To Last”
  

  
  

                January 25 2012
  

  
  

                
	BIO Calls On the Administration and Congress to Embrace Proposals to Unleash the Promise of Biotechnology...
  

  

  		
	  

      
  

                Wisconsin Bioscience Fund Makes Good Business Sense
  

  
  

                November 16 2011
  

  
  

                
	Self-Funding Program Supported by Leading Biotech Trade Associations

	
	WASHINGTON, D.C. (November 16, 2011)...
  

  

  		
	  

      
  

                BIO Praises Passage of Small Company Capital Formation Act
  

  
  

                November 2 2011
  

  
  

                
	Washington, DC (November 2, 2011) – The Biotechnology Industry Organization (BIO) strongly supports the Small...
  

  

  		
	  

      
  

                Missouri Science and Innovation Reinvestment Act Will Spur Economic Growth
  

  
  

                October 26 2011
  

  
  

                
	WASHINGTON, D.C. (October 26, 2011) – Missouri Governor Jay Nixon signed Senate Bill 7, the Missouri Science...
  

  

      

  
  
  
      


  
    More Press Releases →